Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins

FEBS Letters

Volumn 555, Issue 3, 2003, Pages 597-600

  Actis Goretta, Lucas ^a   Ottaviani, Javier I ^a   Keen, Carl L ^b   Fraga, Cesar G ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cocoa; Flavonoid; Hypertension; Oxidative stress

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FLAVAN DERIVATIVE; HIPPURYLHISTIDYLLEUCINE; MEMBRANE PROTEIN; PHENYLALANYLGLYCINE; PROCYANIDIN DERIVATIVE; TETRAMER;

ARTICLE; CELL MEMBRANE; COMPETITIVE INHIBITION; CORONARY RISK; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SUBSTRATE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

THEOBROMA CACAO;

EID: 0346366814     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)01355-3     Document Type: Article

References (33)

1. Middleton E.J., Kandaswami C., Theoharides T.C. Pharmacol. Rev. 52:2000;673-751.
2. Hollman P.C.H. J. Sci. Food Agric. 81:2001;842-852.
3. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., van Leeuwen P.A. Am. J. Clin. Nutr. 74:2001;418-425.
4. Kris-Etherton P.M., Keen C.L. Curr. Opin. Lipidol. 13:2002;41-49.
5. Hammerstone J.F., Lazarus S.A., Schmitz H.H. J. Nutr. 130:2000;2086S-2092S.
6. Fulcrand H., Remy S., Souquet J.M., Cheynier V., Moutounet M. J. Agric. Food Chem. 47:1999;1023-1028.
7. Pearson D.A., Schmitz H.H., Lazarus S.A., Keen C.L. Methods Enzymol. 335:2001;350-360.
8. Ottaviani J.I., Carrasquedo F., Keen C.L., Lazarus S.A., Schmitz H.H., Fraga C.G. Arch. Biochem. Biophys. 406:2002;203-208.
9. Rein D., Paglieroni T.G., Wun T., Pearson D.A., Schmitz H.H., Gosselin R., Keen C.L. Am. J. Clin. Nutr. 72:2000;30-35.
10. Holt R.R., Schramm D.D., Keen C.L., Lazarus S.A., Schmitz H.H. JAMA. 287:2002;2212-2213.
11. Mackenzie, G.G., Carrasquedo, F., Delfino, J.M., Keen, C.L., Fraga, C.G. and Oteiza, P.I. (2003) FASEB J. (in press, 10.1096/fj.03-0402fje).
12. Dzau V.J. Hypertension. 37:2001;1047-1052.
13. Schiffrin E.L. Am. J. Med. 113:2002;409-418.
14. Aviram M., Dornfeld L. Atherosclerosis. 158:2001;195-198.
15. Bormann H., Melzig M.F. Pharmazie. 55:2000;129-132.
16. Hackl L.P., Cuttle G., Dovichi S.S., Lima-Landman M.T., Nicolau M. Pharmacology. 65:2002;182-186.
17. Lacaille D., Franck U., Wagner H. Phytomedicine. 8:2001;47-52.
18. Kameda K., Takaku T., Okuda H., Kimura Y., Okuda T., Hatano T., Agata I., Arichi S. J. Nat. Prod. 50:1987;680-683.
19. Diebolt M., Bucher B., Andriantsitohaina R. Hypertension. 38:2001;159-165.
20. Taubert D., Berkels R., Roesen R., Klaus W. JAMA. 290:2003;1029-1030.
21. Cushman D.W., Cheung H.S. Biochem. Pharmacol. 20:1971;1637-1648.
22. Holmquist B., Bunning P., Riordan J.F. Anal. Biochem. 95:1979;540-548.
23. Mehanna A.S., Dowling M. J. Pharm. Biomed. Anal. 19:1999;967-973.
24. Duffy S.J., Keaney J.F. Jr., Holbrook M., Gokce N., Swerdloff P.L., Frei B., Vita J.A. Circulation. 104:2001;151-156.
25. Liu J.C., et al. Life Sci. 73:2003;1543-1555.
26. Meunier M.T., Villie F., Jonadet M., Bastide J., Bastide P. Planta Med. 53:1987;12-15.
27. Simon C., Barathieu K., Laguerre M., Schmitter J.M., Fouquet E., Pianet I., Dufourc E.J. Biochemistry. 42:2003;10385-10395.
28. Kaushik J.K., Bhat R. J. Biol. Chem. 278:2003;26458-26465.
29. Shibata A., Suezaki Y., Kamaya H., Ueda I. Biochim. Biophys. Acta. 772:1984;383-392.
30. Holt R.R., et al. Am. J. Clin. Nutr. 76:2002;798-804.
31. Verstraeten S.V., Keen C.L., Schmitz H.H., Fraga C.G., Oteiza P.I. Free Radic. Biol. Med. 1:2003;84-92.
32. Kessler S.P., deS Senanayake P., Scheidemantel T.S., Gomos J.B., Rowe T.M., Sen G.C. J. Biol. Chem. 278:2003;21105-21112.
33. de Cavanagh E.M., Piotrkowski B., Basso N., Stella I., Inserra F., Ferder L., Fraga C.G. FASEB J. 17:2003;1096-1098.